Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BioStem Expands Services | Contract Pharma

What are you searching for?

Sign in
Breaking News

BioStem Expands Services

Opens 503b pharmaceutical and stem cell research lab in Florida

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BioStem Technologies has opened its new laboratory and corporate offices in Pompano Beach, FL, enabling it to leverage its vertical integration strategy in the health, wellness and biotechnology sectors. The lab will serve as the quality, R&D, and pharmaceutical manufacturing laboratory, not only for the company’s in-house operations, but also for its contract formulation and contract manufacturing services.

The Company is in the process of finalizing its certifications for the ISO 8, 7, and 5 suites, as well as validation of the cGMP and cGLP areas. Corporate operations are expected to move to the new facility in the second quarter of 2017, while the operations of qualified pharma ingredients, one of the company’s subsidiaries, will remain at its current location in Oakland Park, FL.

“With the recent regulation changes we amended our original facility design to comply with FDA 503b regulations, which caused an extension to our timeline, but I couldn’t be prouder of this new state-of-the-art facility,” said Henry Van Vurst, founder and chief executive officer, BioStem.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters